New Key Statistics Module, Z-Score and F-Score
NAS:ETON Key Ratios
| Market Cap $ M | 88.11 |
| Enterprise Value $ M | 72.12 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | 13.72 |
| Price/Book | 5.70 |
| Price/Sales | 2.80 |
| Price/Free Cash Flow | 13.14 |
| Price/Owner Earnings | 42.35 |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 31.00 |
| EPS (TTM) $ | -0.03 |
| Beneish M-Score | -3.13 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | 60.40 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -60.51 |
| EV-to-EBITDA | -247.85 |
| PEG | -- |
| Shares Outstanding M | 25.69 |
| Net Margin (%) | -2.96 |
| Operating Margin % | -3.77 |
| Pre-tax Margin (%) | -2.18 |
| Quick Ratio | 1.60 |
| Current Ratio | 1.65 |
| ROA % (ttm) | -3.27 |
| ROE % (ttm) | -6.37 |
| ROIC % (ttm) | -23.44 |
| Dividend Yield % | -- |
| Altman Z-Score | 0.02 |
ETON Number of Guru Trades
ETON Volume of Guru Trades
Gurus Latest Trades with NAS:ETON
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:ETON is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Eton Pharmaceuticals Inc Insider Transactions
No Available Data
News about NAS:ETON
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers